Disparities in Mortality and Health Care Utilization for 460,851 Hospitalized Patients with Cirrhosis and Hepatic Encephalopathy

[1] Vilstrup H(2014)Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver Hepatology 60 715-735

[2] Amodio P(2001)Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients J Hepatol 35 37-45

[3] Bajaj J(1986)Survival and prognostic indicators in compensated and decompensated cirrhosis Dig Dis Sci 31 468-475

[4] Cordoba J(2015)Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010 Gastroenterology 148 967-77 e2-252

[5] Ferenci P(2012)Hospital readmissions among patients with decompensated cirrhosis Am J Gastroenterol 107 247-1457

[6] Mullen KD(2012)In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009 Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 10 1034-41 e1-1423

[7] Amodio P(2019)Increasing Burden of hepatic encephalopathy among hospitalized adults: an analysis of the 2010-2014 national inpatient sample Dig Dis Sci 64 1448-220

[8] Del Piccolo F(2016)Evaluating strategies for reducing health disparities by addressing the social determinants of health Health Aff (Millwood) 35 1416-281

[9] Petteno E(2008)Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study Hepatology 48 214-584

[10] Mapelli D(2014)Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) J Hepatol 60 275-1708

[1] Vilstrup H(2014)Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver Hepatology 60 715-735

[2] Amodio P(2001)Prevalence and prognostic value of quantified electroencephalogram (EEG) alterations in cirrhotic patients J Hepatol 35 37-45

[3] Bajaj J(1986)Survival and prognostic indicators in compensated and decompensated cirrhosis Dig Dis Sci 31 468-475

[4] Cordoba J(2015)Decreasing mortality among patients hospitalized with cirrhosis in the United States from 2002 through 2010 Gastroenterology 148 967-77 e2-252

[5] Ferenci P(2012)Hospital readmissions among patients with decompensated cirrhosis Am J Gastroenterol 107 247-1457

[6] Mullen KD(2012)In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009 Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 10 1034-41 e1-1423

[7] Amodio P(2019)Increasing Burden of hepatic encephalopathy among hospitalized adults: an analysis of the 2010-2014 national inpatient sample Dig Dis Sci 64 1448-220

[8] Del Piccolo F(2016)Evaluating strategies for reducing health disparities by addressing the social determinants of health Health Aff (Millwood) 35 1416-281

[9] Petteno E(2008)Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study Hepatology 48 214-584

[10] Mapelli D(2014)Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF) J Hepatol 60 275-1708